A saliva-based test that rapidly and accurately diagnoses concussions is expected to be available to physicians in 2023 following a patent awarded to Quadrant Biosciences, Penn State and the State University of New York by the U.S. Patent and Trademark Office. The patent covers an essential component of the team’s Clarifi mTBI Saliva Test, which was developed after several years of research.
↧